US · Healthcare · Medical Instruments & Supplies
EPS came in at -0.40 against a street estimate of -0.12 — a miss of 233.3%.
Analysts rate Nexgel Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $2.00.
| Fund | Stake |
|---|---|
| Susquehanna International Group, LLP | 0.87% |
| Virtu Financial LLC | 0.81% |
| Geode Capital Management, LLC | 0.74% |
| HRT FINANCIAL LLC | 0.71% |
| Morgan Stanley - Brokerage Accounts | 0.56% |
| Vanguard Capital Management, LLC | 0.50% |
| Citadel Advisors Llc | 0.42% |
| Vanguard Fiduciary Trust Co | 0.35% |
| Action | Detail | Date |
|---|---|---|
| Split | 1 : 20 effective Oct 12, 2026 | 2026-10-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nexgel Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.